Cargando…

Infectious diseases in China in the post-SARS era

Detalles Bibliográficos
Autores principales:	Gibney, Katherine B, Hall, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2017
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128671/ https://www.ncbi.nlm.nih.gov/pubmed/28412151 http://dx.doi.org/10.1016/S1473-3099(17)30168-8

Ejemplares similares

Veterinary infectious diseases control in China
por: Zhang, Xiaodong
Publicado: (2019)

Epidemiologic changes of infectious diseases in the post-SARS era in China, 2004–2018
por: Luo, Yizhe, et al.
Publicado: (2023)

Modernising infectious disease surveillance and an early-warning system: The need for China's action
por: Xu, Lei, et al.
Publicado: (2022)

Exploring Castleman disease in China: pre-IL-6 treatment era and advancements in knowledge
por: Zhong, Nian-Nian, et al.
Publicado: (2023)

Thinking on the informatization development of China's healthcare system in the post-COVID-19 era
por: Zhang, Ming, et al.
Publicado: (2021)

Risks of lung transplantation in the SARS-CoV-2 era
por: Meyer, Keith C
Publicado: (2021)

Sensor-aided continuous care and self-management: implications for the post-COVID era
por: Zhao, Megan, et al.
Publicado: (2020)

National brain tumour registry: a new era of research collaboration with China
por: Valvi, Santosh, et al.
Publicado: (2023)

Post-COVID era: Time to re-introduce “cardiorespiratory fitness” as a vital sign
por: Babu, Abraham Samuel, et al.
Publicado: (2022)

Moving forward: embracing challenges as opportunities to improve medical education in the post-COVID era
por: Kim, Kyong-Jee
Publicado: (2022)

Wastewater surveillance for rapid identification of infectious diseases in prisons
por: Hassard, Francis, et al.
Publicado: (2022)

Travel measures in the SARS-CoV-2 variant era need clear objectives
por: Kucharski, Adam J, et al.
Publicado: (2022)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

Public health surveillance of infectious diseases: beyond point mutations
por: Goodman, Laura B, et al.
Publicado: (2021)

Technology to advance infectious disease forecasting for outbreak management
por: George, Dylan B., et al.
Publicado: (2019)

SARS-CoV-2: can isolation be limited to those who are truly infectious?
por: Vink, Elen, et al.
Publicado: (2022)

Empowering African genomics for infectious disease control
por: Folarin, Onikepe A, et al.
Publicado: (2014)

Nuanced risk assessment for emerging infectious diseases
por: Fisman, David N, et al.
Publicado: (2014)

REACTing: the French response to infectious disease crises
por: Delfraissy, Jean-François, et al.
Publicado: (2016)

Infectious diseases compensation in the USA: the relative value
por: El Helou, Guy, et al.
Publicado: (2022)

Addressing the socioeconomic divide in computational modeling for infectious diseases
por: Tizzoni, Michele, et al.
Publicado: (2022)

Developing medical imaging AI for emerging infectious diseases
por: Huang, Shih-Cheng, et al.
Publicado: (2022)

Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?
por: Driessche, Koen Vanden, et al.
Publicado: (2021)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

Disease surveillance for the COVID-19 era: time for bold changes
por: Morgan, Oliver W, et al.
Publicado: (2021)

The value of early transmission dynamic studies in emerging infectious diseases
por: McBryde, Emma
Publicado: (2020)

Climate change and infectious disease: time for a new normal?
por: Heffernan, Claire
Publicado: (2015)

The cost and challenge of vaccine development for emerging and emergent infectious diseases
por: Maslow, Joel N
Publicado: (2018)

COVID-19 through the Latinx infectious disease doctor's eyes
por: Gardner, Annelys Roque
Publicado: (2021)

The importance of molecular diagnostics for infectious diseases in low-resource settings
por: Okeke, Iruka N., et al.
Publicado: (2021)

How outbreaks in different settings contribute to the transmission of SARS-CoV-2 in the era of “living with COVID”: the case of Japan
por: Leung, Char, et al.
Publicado: (2023)

Early life immunity in the era of systems biology: understanding development and disease
por: Schaffert, Steven, et al.
Publicado: (2018)

Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
por: Kam, Kai-Qian, et al.
Publicado: (2020)

Single cell genomics of bacterial pathogens: outlook for infectious disease research
por: McLean, Jeffrey S, et al.
Publicado: (2014)

Exposure science in an infectious disease pandemic: who do we want to be?
por: Clougherty, Jane E.
Publicado: (2020)

Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission
por: Lee, Vernon J, et al.
Publicado: (2020)

Infectious diseases science in Africa takes a leading place in the world
por: de Oliveira, Tulio
Publicado: (2022)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)

Endemic SARS-CoV-2 will maintain post-pandemic immunity
por: Veldhoen, Marc, et al.
Publicado: (2021)

Global health and data-driven policies for emergency responses to infectious disease outbreaks
por: Kozlakidis, Zisis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nj35i3l1ao6vksg8cojk8g0cej